Press Releases

Press Releases

May 10, 2019
Organogenesis Holdings Inc. Reports First Quarter 2019 Financial Results
CANTON, Mass. , May 10, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO ), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today
May 1, 2019
Organogenesis Receives Innovative Technology Contract from Vizient
CANTON, Mass. , May 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO ), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced
April 30, 2019
Latest Wound Care Research from Organogenesis Highlighted at SAWC Spring 2019
CANTON, Mass. and SAN ANTONIO , April 30, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO ), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine
April 1, 2019
Organogenesis Compliant With Nasdaq Listing Criteria
CANTON, Mass. , April 01, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq:  ORGO ), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine
Displaying 11 - 20 of 27


Shareholder Tools